Breast Cancer in Pregnancy

Breast cancer associated with pregnancy – a review of therapeutic approaches

“…Due to its high teratogenic effect, it is contraindicated in the first trimester, where the risk of defects reaches up to 10 -20%. It is recommended that the drugs be discontinued after the 35th week of pregnancy and three weeks before the scheduled delivery date, as they affect bone marrow function and, as a consequence, haematological complications may occur at birth [37].…”

“…BC chemotherapy uses cytostatic drugs with different mechanisms of action and safety profile. The most commonly used PrBC treatment regimen is based on anthracyclines [37]. Neutropenia, oral ulceration, anaphylaxis and cardiac abnormalities can occur in women taking drugs from this group.…”